Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
18.50
+0.20 (1.09%)
Mar 31, 2025, 1:19 PM EDT - Market open
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Alignment Healthcare stock have an average target of 15.35, with a low estimate of 9.00 and a high estimate of 21. The average target predicts a decrease of -17.03% from the current stock price of 18.50.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 2 | 2 | 3 |
Buy | 2 | 2 | 3 | 3 | 4 | 4 |
Hold | 4 | 4 | 2 | 2 | 2 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 9 | 8 | 9 | 11 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Hold Maintains $14 → $17 | Hold | Maintains | $14 → $17 | -8.11% | Mar 6, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $14 → $21 | Buy | Maintains | $14 → $21 | +13.51% | Mar 4, 2025 |
B of A Securities | B of A Securities | Strong Buy Maintains $16 → $19 | Strong Buy | Maintains | $16 → $19 | n/a | Mar 4, 2025 |
Stifel | Stifel | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | -2.70% | Feb 28, 2025 |
Barclays | Barclays | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -51.35% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
3.78B
from 2.70B
Increased by 39.82%
Revenue Next Year
4.73B
from 3.78B
Increased by 25.16%
EPS This Year
-0.41
from -0.67
EPS Next Year
-0.25
from -0.41
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.0B | 5.3B | 5.4B | ||
Avg | 3.8B | 4.7B | 5.2B | ||
Low | 3.4B | 4.0B | 4.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 46.3% | 39.3% | 14.2% | ||
Avg | 39.8% | 25.2% | 9.3% | ||
Low | 24.5% | 6.3% | 3.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.29 | -0.04 | 0.15 | ||
Avg | -0.41 | -0.25 | -0.11 | ||
Low | -0.53 | -0.46 | -0.37 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.